Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cancer Immunology: A Translational Medicine Context Publisher



Rezaei N1, 2
Authors

Source: Cancer Immunology: A Translational Medicine Context Published:2015


Abstract

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume is focused on immunopathology of cancers. The interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field. Over the past decade, understanding of the interactions between the immune system and cancerous cells has increased markedly, leading to the development of combinatorial immunotherapeutic strategies to combat cancer. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists. © Springer-Verlag Berlin Heidelberg 2015.
Related Docs
View other Related Docs
1. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
2. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
3. Cancer Immunology: A Translational Medicine Context, Second Edition, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (13)
Mahmood Naderi (1)
Other Related Docs
4. The Molecular Mechanism of Actions and Clinical Utilities of Tumor Infiltrating Lymphocytes in Gastrointestinal Cancers: A Comprehensive Review and Future Prospects Toward Personalized Medicine, Frontiers in Immunology (2023)
5. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
6. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
7. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
8. The Evolving Landscape of Predictive Biomarkers in Immuno-Oncology With a Focus on Spatial Technologies, Clinical and Translational Immunology (2020)
9. Resistance to Immunotherapy in Human Malignancies: Mechanisms, Research Progresses, Challenges, and Opportunities, Journal of Cellular Physiology (2022)
10. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
11. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
12. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
13. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
14. The Potential Role of Immunotherapy in Wilms’ Tumor: Opportunities and Challenges, Current Pharmaceutical Design (2023)
15. Advances in Therapeutic Targeting of Immune Checkpoints Receptors Within the Cd96-Tigit Axis: Clinical Implications and Future Perspectives, Expert Review of Clinical Immunology (2022)
16. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
17. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
18. Addressing Cancer Immunotherapy Research in Iran: Adoptive Cell Therapy on the Horizon, Cytotherapy (2018)
19. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
20. Don't Eat Me/Eat Me Signals As a Novel Strategy in Cancer Immunotherapy, Heliyon (2023)